351 related articles for article (PubMed ID: 35792761)
1. Liver cirrhosis and immune dysfunction.
Hasa E; Hartmann P; Schnabl B
Int Immunol; 2022 Sep; 34(9):455-466. PubMed ID: 35792761
[TBL] [Abstract][Full Text] [Related]
2. Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers.
Trebicka J; Hernaez R; Shawcross DL; Gerbes AL
Gut; 2024 May; 73(6):1015-1024. PubMed ID: 38527788
[TBL] [Abstract][Full Text] [Related]
3. The microbiota in cirrhosis and its role in hepatic decompensation.
Trebicka J; Macnaughtan J; Schnabl B; Shawcross DL; Bajaj JS
J Hepatol; 2021 Jul; 75 Suppl 1(Suppl 1):S67-S81. PubMed ID: 34039493
[TBL] [Abstract][Full Text] [Related]
4. Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis.
Bajaj JS; Vargas HE; Reddy KR; Lai JC; O'Leary JG; Tandon P; Wong F; Mitrani R; White MB; Kelly M; Fagan A; Patil R; Sait S; Sikaroodi M; Thacker LR; Gillevet PM
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):756-765.e3. PubMed ID: 30036646
[TBL] [Abstract][Full Text] [Related]
5. Utilizing the gut microbiome in decompensated cirrhosis and acute-on-chronic liver failure.
Trebicka J; Bork P; Krag A; Arumugam M
Nat Rev Gastroenterol Hepatol; 2021 Mar; 18(3):167-180. PubMed ID: 33257833
[TBL] [Abstract][Full Text] [Related]
6. The Role of Gut Dysbiosis in Acute-on-Chronic Liver Failure.
Kim SE; Park JW; Kim HS; Jang MK; Suk KT; Kim DJ
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769109
[TBL] [Abstract][Full Text] [Related]
7. Alterations in Gut Microbiome in Cirrhosis as Assessed by Quantitative Metagenomics: Relationship With Acute-on-Chronic Liver Failure and Prognosis.
Solé C; Guilly S; Da Silva K; Llopis M; Le-Chatelier E; Huelin P; Carol M; Moreira R; Fabrellas N; De Prada G; Napoleone L; Graupera I; Pose E; Juanola A; Borruel N; Berland M; Toapanta D; Casellas F; Guarner F; Doré J; Solà E; Ehrlich SD; Ginès P
Gastroenterology; 2021 Jan; 160(1):206-218.e13. PubMed ID: 32941879
[TBL] [Abstract][Full Text] [Related]
8. Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure.
Clària J; Stauber RE; Coenraad MJ; Moreau R; Jalan R; Pavesi M; Amorós À; Titos E; Alcaraz-Quiles J; Oettl K; Morales-Ruiz M; Angeli P; Domenicali M; Alessandria C; Gerbes A; Wendon J; Nevens F; Trebicka J; Laleman W; Saliba F; Welzel TM; Albillos A; Gustot T; Benten D; Durand F; Ginès P; Bernardi M; Arroyo V;
Hepatology; 2016 Oct; 64(4):1249-64. PubMed ID: 27483394
[TBL] [Abstract][Full Text] [Related]
9. Altered Microbiome in Patients With Cirrhosis and Complications.
Acharya C; Bajaj JS
Clin Gastroenterol Hepatol; 2019 Jan; 17(2):307-321. PubMed ID: 30099098
[TBL] [Abstract][Full Text] [Related]
10. Complement C3 Facilitates Stratification of Stages of Chronic Hepatitis B and Signifies Development of Acute-on-Chronic Liver Failure in Acute Decompensated Cirrhosis.
Chen C; Yuan Z; Li W; Fei L; Ji L; Huang Q; Zhang S; Chen L
Adv Ther; 2023 Mar; 40(3):1171-1186. PubMed ID: 36652176
[TBL] [Abstract][Full Text] [Related]
11. Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis.
Zanetto A; Pelizzaro F; Campello E; Bulato C; Balcar L; Gu W; Gavasso S; Saggiorato G; Zeuzem S; Russo FP; Mandorfer M; Reiberger T; Trebicka J; Burra P; Simioni P; Senzolo M
J Hepatol; 2023 Feb; 78(2):301-311. PubMed ID: 36150575
[TBL] [Abstract][Full Text] [Related]
12. The gut-liver axis in immune remodeling of hepatic cirrhosis.
Guan H; Zhang X; Kuang M; Yu J
Front Immunol; 2022; 13():946628. PubMed ID: 37408838
[TBL] [Abstract][Full Text] [Related]
13. Predictors of mortality among patients with compensated and decompensated liver cirrhosis: the role of bacterial infections and infection-related acute-on-chronic liver failure.
Sargenti K; Prytz H; Nilsson E; Kalaitzakis E
Scand J Gastroenterol; 2015 Jul; 50(7):875-83. PubMed ID: 25697824
[TBL] [Abstract][Full Text] [Related]
14. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology.
Trebicka J; Fernandez J; Papp M; Caraceni P; Laleman W; Gambino C; Giovo I; Uschner FE; Jimenez C; Mookerjee R; Gustot T; Albillos A; Bañares R; Janicko M; Steib C; Reiberger T; Acevedo J; Gatti P; Bernal W; Zeuzem S; Zipprich A; Piano S; Berg T; Bruns T; Bendtsen F; Coenraad M; Merli M; Stauber R; Zoller H; Ramos JP; Solè C; Soriano G; de Gottardi A; Gronbaek H; Saliba F; Trautwein C; Özdogan OC; Francque S; Ryder S; Nahon P; Romero-Gomez M; Van Vlierberghe H; Francoz C; Manns M; Garcia E; Tufoni M; Amoros A; Pavesi M; Sanchez C; Curto A; Pitarch C; Putignano A; Moreno E; Shawcross D; Aguilar F; Clària J; Ponzo P; Jansen C; Vitalis Z; Zaccherini G; Balogh B; Vargas V; Montagnese S; Alessandria C; Bernardi M; Ginès P; Jalan R; Moreau R; Angeli P; Arroyo V;
J Hepatol; 2020 Oct; 73(4):842-854. PubMed ID: 32673741
[TBL] [Abstract][Full Text] [Related]
15. Targeting the gut-liver-immune axis to treat cirrhosis.
Tranah TH; Edwards LA; Schnabl B; Shawcross DL
Gut; 2021 May; 70(5):982-994. PubMed ID: 33060124
[TBL] [Abstract][Full Text] [Related]
16. Microbiota, cirrhosis, and the emerging oral-gut-liver axis.
Acharya C; Sahingur SE; Bajaj JS
JCI Insight; 2017 Oct; 2(19):. PubMed ID: 28978799
[TBL] [Abstract][Full Text] [Related]
17. Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF.
Moreau R; Clària J; Aguilar F; Fenaille F; Lozano JJ; Junot C; Colsch B; Caraceni P; Trebicka J; Pavesi M; Alessandria C; Nevens F; Saliba F; Welzel TM; Albillos A; Gustot T; Fernández J; Moreno C; Baldassarre M; Zaccherini G; Piano S; Montagnese S; Vargas V; Genescà J; Solà E; Bernal W; Butin N; Hautbergue T; Cholet S; Castelli F; Jansen C; Steib C; Campion D; Mookerjee R; Rodríguez-Gandía M; Soriano G; Durand F; Benten D; Bañares R; Stauber RE; Gronbaek H; Coenraad MJ; Ginès P; Gerbes A; Jalan R; Bernardi M; Arroyo V; Angeli P; ; ;
J Hepatol; 2020 Apr; 72(4):688-701. PubMed ID: 31778751
[TBL] [Abstract][Full Text] [Related]
18. Cirrhosis-associated immune dysfunction.
Albillos A; Martin-Mateos R; Van der Merwe S; Wiest R; Jalan R; Álvarez-Mon M
Nat Rev Gastroenterol Hepatol; 2022 Feb; 19(2):112-134. PubMed ID: 34703031
[TBL] [Abstract][Full Text] [Related]
19. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
[TBL] [Abstract][Full Text] [Related]
20. Altered profile of human gut microbiome is associated with cirrhosis and its complications.
Bajaj JS; Heuman DM; Hylemon PB; Sanyal AJ; White MB; Monteith P; Noble NA; Unser AB; Daita K; Fisher AR; Sikaroodi M; Gillevet PM
J Hepatol; 2014 May; 60(5):940-7. PubMed ID: 24374295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
